2020 annual financial data
Compass Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -27,812,000 USD and net income was -29,500,000 USD.
Operating cash flow was -26,803,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,812,000 USD
- Net income
- -29,500,000 USD
- Operating cash flow
- -26,803,000 USD